IDF Europe Symposium at EASD - Improving the HCP-PwD interaction for better health outcomes, quality of life and resilient health systems

Last update: 26/09/2022

People living with type 2 diabetes identify the relationship with their primary healthcare professional (often, at least at diagnosis, a GP) as critical to achieving optimal health outcomes and quality of life. The IDF Europe symposium explored what the key components of this relationship are and what needs to be put in place to ensure that this interaction is effective and promotes a patient-centred and holistic approach to diabetes management.

After an introduction on the work conducted by IDF Europe’s platform of people living with diabetes on the HCP-PwD interaction, three panels addressed different approaches/solutions that contribute to improving the quality of the interaction between PwD and HCPs:

  1. The HCP as member of a multi-disciplinary team
  2. Guidelines from theory to point of care
  3. The HCP as a conduit to the best possible care – looking beyond standard practice: education and engagement in clinical trials

Watch the recording of the symposium

Download the presentation on the work of IDF Europe's Platform of People living with Type 2 Diabetes here


Symposium chaired and moderated by Dr Niti Pall, Chair, IDF Europe

16.00-16:05: Welcome and introduction, Dr Niti Pall

16.05-16.15: Presentation of the work of IDF Europe’s Platform of People living with Type 2 Diabetes

Download the presentation here

16.15-16.40: Panel 1 – The HCP-PwD relationship: how to support a multi-disciplinary approach?

The panellists discussed the prerequisites to the effectiveness and quality of a relationship which is increasingly becoming multi-dimensional through the move towards integrated, multi-disciplinary care (within a general PHC system/dedicated diabetes clinics), involving a multitude of HCPs across several levels of care.


  • João Filipe Raposo, Medical Director, APDP (Portuguese Diabetes Association), Portugal
  • Elena Shelestova, Diabetes Educator, Georgian Union of Diabetes and Endocrine Association, Georgia
  • Yvonne Johns, Type 2 Diabetes Advocate, UK
  • Pinar Topsever, Vice-Chair, Primary Care Diabetes Europe, Turkey

16.40-17.05: Panel 2 – Guidelines from theory to point of care; GUARDIANS FOR HEALTH implementation initiative

The panellists discussed clinical inertia in the management of patients with type 2 diabetes. They considered how the GUARDIANS FOR HEALTH initiative can support the implementation of guideline-directed therapies to reduce the risk of cardiorenal complications.


  • Naresh Kanumilli, Northenden Group Practice, Manchester, UK
  • Konstantinos Makrilakis, IDF Europe Board Member, Greece
  • Yvonne Johns, Type 2 Diabetes Advocate, UK

17.05-17.25: Panel 3 – How can traditional and new decentralised clinical trials support PwD empowerment and self-management and improve PwD-HCP interaction?

The panellists discussed the role of primary care professionals in clinical trials and the impact of clinical trials on a PwD’s empowerment and how both aspects can best contribute to the HCP-PwD interaction and improve health outcomes.


  • Mia Bajramagic, Type 1 Diabetes advocate, Coordinator, Trials@Home Patient Expert Panel, Belgium
  • Manuel Cabezas, Julius Clinical Scientific Officer, Netherlands
  • Tatjana Milenkovic, IDF Europe Board Member, North Macedonia

17.25-17.30 Wrap-up and Closing remarks – Prof. Nebojsa Lalic, IDF Europe Chair-Elect

You can download the list of the panellists and their short bios here.

Back to news
© 2022 International Diabetes Federation Disclaimer Privacy policy